Published in AIDS Weekly, September 11th, 2006
"Treatment of human immunodeficiency virus type I with protease inhibitors (PIs) is associated with the emergence of resistance-associated mutations. Treatment-characterized datasets have been used to identify novel treatment-associated protease mutations," wrote investigators in the United States.
According to R.M. Kagan and colleagues at Quest Diagnostic Nichols Institute, "In this study, we utilized two large reference laboratory databases (>11,5000 viral sequences) to identify nonestablished...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.